The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York peptides #fda #longevity #glp1 #precisionmedicine #compounding Katherine Erickson GOP lawmakers ask RFK Jr. to make FDA unleash risky peptides like BPC 157 The Niche FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog